Recent updates on the management of autoimmune hepatitis

A Komori - Clinical and molecular hepatology, 2020 - pmc.ncbi.nlm.nih.gov
Autoimmune hepatitis (AIH) is an immunoinflammatory chronic liver disease with dynamic
and rather heterogeneous disease manifestations. A trend of increasing prevalence of AIH …

Second-line and third-line therapy for autoimmune hepatitis: a position statement from the European Reference Network on Hepatological Diseases and the …

AW Lohse, M Sebode, MH Jørgensen, H Ytting… - Journal of …, 2020 - Elsevier
Most patients with autoimmune hepatitis respond well to standard immunosuppressive
therapy with steroids and azathioprine, and while untreated disease is usually fatal, patients …

[PDF][PDF] Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the American Association for the Study …

CL Mack, D Adams, DN Assis, N Kerkar… - …, 2020 - Wiley Online Library
Abbreviations: AASLD, American Association for the Study of Liver Diseases; AIH,
autoimmune hepatitis; ALF, acute liver failure; ALT, alanine aminotransferase; AMA …

The Asian Pacific Association for the Study of the Liver clinical practice guidance: the diagnosis and management of patients with autoimmune hepatitis

G Wang, A Tanaka, H Zhao, J Jia, X Ma… - Hepatology …, 2021 - Springer
Guiqiang Wang1, 18· Atsushi Tanaka2· Hong Zhao1, 1 8· Jidong Jia3· **ong Ma4· Kenichi
Harada5· Fu‑Sheng Wang6· Lai Wei7· Qixia Wang4· Ying Sun6· Yuan Hong1· Huiying …

[HTML][HTML] Autoimmune hepatitis: 2019 update

A Tanaka - Gut and Liver, 2020 - ncbi.nlm.nih.gov
Autoimmune hepatitis (AIH) is a chronic inflammatory liver disease, characterized by the
elevation of aminotransferases, presence of anti-nuclear antibody or anti-smooth muscle …

Systematic review with meta‐analysis: mycophenolate mofetil as a second‐line therapy for autoimmune hepatitis

P Santiago, I Schwartz, L Tamariz… - Alimentary …, 2019 - Wiley Online Library
Background First‐line treatment for autoimmune hepatitis (AIH) typically includes
corticosteroids in combination with azathioprine. Mycophenolate mofetil (MMF) is often used …

Autoimmune hepatitis: a diagnostic and therapeutic overview

LA Mercado, F Gil-Lopez, RM Chirila, DM Harnois - Diagnostics, 2024 - mdpi.com
Autoimmune hepatitis is an immune-mediated inflammatory condition of the liver of
undetermined cause that affects both sexes, all ages, races, and ethnicities. Its clinical …

Efficacy and safety of mycophenolate mofetil in treating immune‐related hepatitis induced by immune checkpoint inhibitor use: A retrospective study

Y Kadokawa, S Inoue, A Tatsumi, M Uchida… - JGH …, 2023 - Wiley Online Library
Abstract Background and Aim To investigate the outcomes in eight Japanese patients with
cancer treated with mycophenolate mofetil (MMF) and corticosteroids for immune checkpoint …

Treatment of autoimmune hepatitis

A Goel, P Kwo - Clinics in Liver Disease, 2024 - liver.theclinics.com
Autoimmune hepatitis (AIH) is a chronic immune-mediated inflammatory liver disease that
presents across the demographic spectrum. The clinical presentation can range from …

Novel therapeutic targets in autoimmune hepatitis

R Taubert, KL Hupa-Breier, E Jaeckel… - Journal of autoimmunity, 2018 - Elsevier
Autoimmune hepatitis (AIH) is an orphan disease characterized by an autoimmune attack
against hepatocytes. The exact sequence of events that leads to a breach of tolerance is …